Six HIMSS EMRAM Stage 6 Hospitals Awarded at HIMSS Turkey Educational Conference & Exhibition

HIMSS Europe20 - 21 March 2015, Antalya, Turkey.
Six Turkish hospitals will be awarded the prestigious Stage 6 EMRAM award for demonstrating outstanding levels of IT implementation ensuring superior healthcare services and much increased patient safety.

The awards will be presented at the second HIMSS Turkey Educational Conference & Exhibition, which opens its doors in Antalya. The conference, a joint initiative between the Turkish Ministry of Health and HIMSS Europe, is the second in a series of five conferences. The conferences will showcase the results of the Turkish EMRAM data collection, which HIMSS is collecting on behalf of the Turkish Ministry of Health to have all 850 public Turkish Hospitals in the HIMSS Analytics database by 2019.

The six HIMSS EMRAM (EMR Adoption Model) Stage 6 hospitals to be awarded are:

  • Tirebolu Devlet Hastanesi, Giresun.
  • Dr. Suat Seren Göğüs Hastalıkları ve Cerrahisi Eğitim ve Araştırma Hastanesi, İzmir
  • Meslek Hastalıkları Hastanesi, Ankara
  • Bandırma Devlet Hastanesi, Balıkesir
  • Fizik Tedavi ve Rehabilitasyon Hastanesi, Bolu
  • Katip Çelebi Üniversitesi Atatürk Eğitim ve Araştırma Hastanesi, İzmir

Dr. Yilmaz Salman, Head Doctor, from Tirebolu Devlet Hastanesi, one of the hospitals that has reached Stage 6 said: "Our IT systems are helping us to coordinate much of our work and keep track of our patient medical and financial information and coordinate between our departments, with HIMSS EMRAM stage 6 we are able to put new goals such as medical decision support system usage in our system. We will continue working to demonstrate a more elaborated system and HIMSS stage 6 acknowledgments which will encourage us even to do more."

The HIMSS Turkey conference takes place March 20 & 21, 2015 at the Titanic Deluxe Belek Hotel in Antalya. The main themes of the conference are public private partnership projects, healthcare IT and mobility, standards in interoperability, patient involvement, personlised medicine and genomics.

H. Stephen Lieber, President and CEO of HIMSS, said: "Turkey is fast becoming a leading figure in Europe in the transformation of health care through information technology. With six new Stage 6 hospitals recognised this year and five identified last year, Turkey now has 11 'flagship' hospitals in terms of EMR adoption. In absolute numbers Turkey now has the third highest share of Stage 6/7 hospitals in Europe trailing only Spain and the Netherlands. This average and the high number of Stage 6 Award recipients brings Turkey in a league with the top EMRAM countries in Europe. I am proud to celebrate this great accomplishment with those who have driven the country to this strong leadership position."

For further information, please visit:
http://www.himssturkey.org

About HIMSS
HIMSS is a global, cause-based, not-for-profit organization focused on better health through information technology (IT). HIMSS leads efforts to optimize health engagements and care outcomes using information technology.

HIMSS is a part of HIMSS WorldWide, a cause-based, global enterprise producing health IT thought leadership, education, events, market research and media services around the world. Founded in 1961, HIMSS WorldWide encompasses more than 52,000 individuals, of which more than two-thirds work in healthcare provider, governmental and not-for-profit organizations across the globe, plus over 600 corporations and 250 not-for-profit partner organizations, that share this cause. HIMSS WorldWide, headquartered in Chicago, serves the global health IT community with additional offices in the United States, Europe, and Asia.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...